KOSPI-listed pharmaceutical firms’ operating profit plunge by 8.9% in third quarter

Korea’s listed pharmaceutical companies saw their third-quarter combined operating profit fall 6.8 percent year-on-year, while net profit dwindle to 14.3%. Sales were up 6.1 percent on average.

The combined net profit of 32 firms listed on the main bourse came to 24.2 billion for the third quarter, down from 15.9 billion won from a year earlier, according to the report compiled by Yakup.com....